Clinical Trial Update: Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update in rheumatoid arthritis patients with moderate to severe disease activity despite methotrexate (with or without other non-biolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2016-07-06